TY  - BOOK
AU  - Osmane,Malik
TI  - Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account
AV  - RS189 .O863 2014eb
U1  - 572 23
PY  - 2014///
CY  - Hamburg, Germany
PB  - Anchor Academic Publishing
KW  - Biological products
KW  - Drugs
KW  - Generic substitution
KW  - Pharmaceutical biotechnology industry
KW  - Electronic books
N1  - Includes bibliographical references
UR  - http://site.ebrary.com/lib/rucke/Doc?id=10856569
ER  -